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inhibit the expression of inflammatory mediators, through down- 
regulation of COX-l, COX-2, and iNOS genes. These effects 
could compensate for cartilage matrix damage. 
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ANTI-PROINFLAMMATORY CYTOKINE 
PHARMACOTHERAPEUTICS 
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Canada; 2Medicine, McGill University Health Centre, Royal 
Victoria Hospital, Montreal, QC, Canada 
Proinflammatory cytokines are pleiotropic bioeffectors that mod- 
ulate a broad range of inflammatory and immunological pro- 
cesses and have been implicated in the etiopathology of in- 
flammatory arthritides. We recently reported on the cellular and 
molecular mechanisms mediating the potent suppression of TNF- 
a, IL-11~ and matrix destructive metalloproteases by prostaglandin 
E2 (PGE2). Here we report on the development of the PGE2 
mimetic combination therapy (DP-837953) that inhibits basal and 
LPS/TLR4 induced TNF-a, IL-11~, and MMP-1 and 9 in human 
and murine synovial membranes and macrophages. In a murine 
model of chronic synovitis (dorsal air pouch), DP837953 dramati- 
cally inhibited granulocyte infiltration and exudate volume as well 
as IL-11~, TNF-a, MIP2, MCP-2 and IL-8 expression and release. 
In a model of inflammatory arthritis (collagen induced arthritis, 
CIA), DP837953 markedly reversed the inflammatory pathology 
by reducing synovial hyperplasia, cartilage erosion and articular 
inflammation. Our results suggest that disease-modifying anti- 
cytokine/anti-inflammatory activity can be achieved with 'small 
molecule' pharmacotherapeutics. 
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CARTILAGE GENE EXPRESSION IN EARLY 
OSTEOARTHRITIS USING THE POND-NUKI MODEL IN 
DOGS 
AM Stoker, JL Cook, K Kuroki, DB Fox 
Comparative Orthopaedic Laboratory, University of Missouri 
Columbia, Columbia, MO 
Aim of Study: To determine the site-specific gene expression ef- 
fects of anterior cruciate ligament ransection (ACL-X) on articular 
cartilage (AC) of the knee during development of OA. 
Methods: Pond-Nuki Model: The ACL in one knee of three adult 
mongrel dogs (mean weight 26.2 kg) was completely transected 
through a lateral parapatellar arthrotomy, the dogs were allowed 
unrestricted use of the limb and the contralateral knee of each 
dog was used as the nonoperated control. After four weeks, the 
dogs were euthanatized and evaluated. Tissue harvest: Separate 
full-thickness cartilage samples were collected from the cranial 
(Cr) and Caudal (Ca) medial (M) femoral (F) condyle (CrMF and 
CaMF), Cr and Ca lateral (L) F (CrLF and CALF), CrM and CaM 
tibial (T) plateau (CrMT and CaMT), CrLT and CaLT of both knees 
and used for gene expression and biochemical evaluation. RNA 
analysis: Total RNA was extracted using the Trispin method, and 
stored at -80°C until used for gene expression analysis. Real time 
RT-PCR analysis was performed on total RNA (11~g) to determine 
the relative gene expression levels of COL 1 and 2, aggrecan 
(Agg), TIMP-1 and -2, MMP-1, -2, -3, -9, and -13, ADAMTS 4 
and 5, INOS, and COX-2 compared to the housekeeping gene 
GAPDH using the QuantiTect SYBR Green PCR master mix. Bio- 
chemical analysis: Total sulfated GAG content was determined 
using the DMMB assay. Total collagen content was determined 
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Fig. 1. Differential gene expression ~n ACL-X compared to control articular 
cartilage by region. Normal font indicates ignificant increase in gene expres- 
sion in the ACL-X tissues compared to normal tissues, withe italics indicates 
significant decrease in ACL-X tissue gene expression. Genes in blue were 
differentially regulated at 2 weeks in that region. Darker shading in a region 
indicates that a larger number of genes showed differential expression i  that 
region. 
by measuring hydroxyprolene (HP) content. Statistical Analysis: 
Relative gene expression levels were determined using QGene. 
Significant differences in gene expression levels were determined 
using REST-XL and biochemical data were analyzed by ANOVA 
with significance at P<0.05. 
Results: Biochemical and Histologicah The CaMT from the ACL- 
X knee had significantly lower GAG content and the lower GAG 
content of the CaMF and CrMF were nearly significant compared 
to contralateral limb. Gene Expression (Fig. 1): Significant dif- 
ferences in gene expression between ACL-X and control knees 
were observed in every region analyzed, and each region exhib- 
ited a unique gene expression profile. 
Conclusions: The regional data from this study correlate well 
to the patterns observed two weeks post-ACL-X (Stoker, OARSI 
2005). The changes seen in the regulation of the genes at 4 
weeks suggest that cells in the articular cartilage are further pro- 
gressing toward degradation and that differential gene expression 
noted at 2 weeks was indicative of these changes. The decreases 
in tissue GAG content in the CaMT and MF correspond to regions 
exhibiting increased ADAMTS 5 and decreased Aggrecan gene 
expression in the ACL-X knee. These data indicate that the ca- 
nine ACL-X model is useful for investigating changes in articular 
cartilage for early changes in OA. 
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KASHIN-BECK DISEASE 
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Evans, C Dent, B Caterson 
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Introduction: Kashin-Beck disease (KBD) is an endemic os- 
teoarthropathy found predominantly in a broad belt across China. 
Postulated aetiologies include a dietary selenium defiency, and 
fungal mcotoxins infiltrating food stores. It manifests as cartilage 
degeneration and necrosis, with pathological changes occurring 
in growth plate and articular cartilage in humans. Previous work 
has established an in vitro system in which chondrocytes are cul- 
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tured and an ex vivo cartilage graft is produced. Subjecting these 
chondrocytes to either selenium (SEL), Nivalenol (NIV) or in com- 
bination during the growth of the graft has been found to alter 
the morphology of the cartilage graft. In addition, the quantity of 
the large aggregating proteoglycan, was significantly reduced in a 
dose dependent manner in the presence of Nivalenol. This study 
aimed to examine the composition of aggrecan from cartilage 
grafts grown in the presence of NIV or SEL alone, or in combi- 
nation to better understand cellular and molecular mechanisms 
underlying the pathogenesis of KBD. 
Methods: Chondrocytes (7 day old bovine cartilage) were 
seeded at high density in MilliCell filter inserts (12mm diam- 
eter; Millipore, MA). Cultures were maintained for 4 weeks in 
DMEM supplemented with 20% heat-inactivated FBS, ascorbate 
(1001~g/ml) and TGFI~2 (5ng/ml) or additionally supplemented 
with either SEL, NIV or both at varying concentrations. Media was 
refreshed thrice weekly and later analysed. At 4 weeks the carti- 
lage grafts were harvested, weighed and extracted in 4M guanid- 
ium chloride containing an inhibitor cocktail for biochemical anal- 
ysis of matrix molecules. Residues were digested with papain. 
Glycosaminoglycan concentration was determined in all samples 
and extracts. Aggrecan and GAG composition was determined 
using Western blotting. 
Results: The total GAG synthesised in a 4week period was sub- 
stantially reduced in chondrocytes cultured in the presence of NIV 
in a dose dependant manner, and to a lesser extent in those cul- 
tures exposed to the highest dose of SEL. However, the amount 
of GAG released into the media remained fairly constant within 
the treatment groups, but a marked reduction was apparent in 
the guanidine extracts of the cartilage grafts. Western blot anal- 
ysis with a series of antibodies on guanidine extracted aggre- 
can showed no substantial changes in the core protein molecular 
weights however analysis demonstrated that KS was reduced in 
NIV treated cultures. Results also indicated that NIV treated cul- 
tures appeared to contain less CS substitutions on the aggrecan 
core protein. 
Discussion: The data on GAG concentrations indicates that 
there is an inability of the GAG to remain within the cartilage 
grafts extracellular matrix.when treated with NIV. Western blot 
analysis indicates minor changes in the composition of the ag- 
grecan in relation to protein core length and CS/KS side chain 
substitutions or length. Further work will investigate the propor- 
tion of aggrecan able to form high molecular weight aggregates, 
the metabolism of link protein and hyaluronan. 
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Hgs PHYSICALLY INTERACTS WITH BMP-RECEPTOR- 
ASSOCIATED Smad5 AND ATTENUATES BMP 
SIGNALING 
T Aigner, J Haag 
Pathology, University of Erlangen-NEtrnberg, Erlangen, Bavaria, 
Germany 
Signaling by members of the Bone Morphogenetic Protein fam- 
ily plays a critical role in cartilage development and differentiation 
as well as maintenance during adulthood. Recently, this poten- 
tial involvement of BMPs in the maintenance and repair of dam- 
aged adult articular cartilage have initiated an interest in the role 
of BMP signaling and the involved signaling pathways in the adult 
tissue. In this study, we identified Hgs as a novel Smad5 interactor 
using a cDNA expression library constructed from human adult 
cartilage. This interaction was confirmed by coimmunoprecipita- 
tion experiments and was shown to be independent of ligand (i.e. 
BMP) stimulation. Overexpression of Hgs resulted in an attenua- 
tion of BMP-dependent ranscriptional responses suggesting that 
Hgs acts as an inhibitor of BMP signaling. Of note, osteoarthritic 
chondrocytes which have been suggested previously to show in- 
creased reactivity to BMP-stimulation showed less expression of 
Hgs. Thus, it is tempting to speculate that both might be related to 
each other given the suppressive effect of BMP-signaling of Hgs 
shown in this study. 
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THE DIFFERENTIAL EXPRESSION OF OPG/RANKL IN 
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Aim of Study: Although the OPG/RANKL ratio is considered a 
key element in the regulation of bone metabolism, there is lit- 
tle data on these factor levels in human osteoarthritic (OA) sub- 
chondral bone. We previously reported that OA patients can be 
discriminated into two subgroups identified by the endogenous 
(low or high) production of PGE2 by osteoblasts that otherwise 
show no different phenotypic features. We investigated the rela- 
tionship between the level of expression of OPG and RANKL in 
both human normal and OA subchondral bone osteoblast sub- 
groups. Furthermore, we analysed the effect of bone remodeling 
factors on OPG and RANKL expression levels as well as on the 
mineralization process. 
Methods: Gene expression was determined using real-time 
PCR. Gene regulation and the mineralization process were mon- 
itored on OA osteoblasts following treatment with vitamin D3 (50 
n M), TG F-I~I (5 ng/m I), I L-1 I~ (100 pg/ml), TN F-~ (5 ng/m I), PG E2 
(500 nM), or PTH (100 nM). 
Results: Human osteoblasts demonstrated a much higher level 
of OPG expression than RANKL. OA expressed less OPG than 
normal; this was more marked in the low OA cells. Compared to 
normal, RANKL levels were increased in low OA and decreased 
in high OA. Correlation analysis revealed that in low OA for any 
given level of OPG expression, the corresponding level of RANKL 
was about 7.5 times greater than in normal. The OPG/RANKL ra- 
tio was diminished in low OA compared to normal or high OA 
(p<0.02 and p<0.03), and markedly increased in high OA com- 
pared to normal. In low OA cells, both vitamin D3 and TGF-I~I 
significantly reduced the OPG/RANKL ratio, IL-11~ had no modi- 
fication, and the ratio markedly increased in response to TNF-~ 
(335-fold), and to a lesser extent to PTH and PGE2 (30- and 7- 
fold). Mineralization patterns generally agree with OPG/RANKL 
levels. 
Conclusion: Data revealed that OPG and RANKL expression 
levels, and consequently the OPG/RANKL ratio, differed accord- 
ing to human OA subchondral bone osteoblast classification. The 
OPG/RANKL balance is disturbed, being decreased in the low 
OA osteoblasts thus favoring RANKL, and increased in the high 
OA osteoblasts. This suggests that the low OA osteoblasts are 
enriched in factors promoting bone resorption, and that the high 
OA cells have reached a more advanced stage in the progression 
of the disease with reduced resorptive properties. The latter may 
be due to a flare in disease activity, in which factors including 
TNF-~ and PGE2 are highly upregulated, thus promoting bone 
deposition. 
